HAB Pharma expands presence with new Dehradun facility, advancing healthcare innovation
HAB Pharmaceutical & Research Ltd. has acquired a 10-acre plot in Dehradun to expand its manufacturing capabilities. The site will feature a new Metered Dose Inhaler (MDI) facility and explore biologics for autoimmune disorders. HAB Pharma aims to bolster its position as a leading contract manufacturer, serving major pharmaceutical companies with high-quality, innovative healthcare solutions.
HAB Pharmaceutical & Research Ltd. has acquired a 10-acre plot in Dehradun to expand its manufacturing capabilities. The site will feature a new Metered Dose Inhaler (MDI) facility and explore biologics for autoimmune disorders. HAB Pharma aims to bolster its position as a leading contract manufacturer, serving major pharmaceutical companies with high-quality, innovative healthcare solutions.
